Xencor

Recent news

• Rating change
  BofA Securities Maintains Xencor(XNCR.US) With Hold Rating, Raises Target Price to $20
  Market Newswire · 2026/8/8
• Rating change
  BofA Securities Maintains Xencor(XNCR.US) With Hold Rating, Maintains Target Price $17
  Market Newswire · 2026/5/14
• Rating change
  CCORF Maintains Xencor(XNCR.US) With Buy Rating, Maintains Target Price $38
  Market Newswire · 2026/5/7
• Rating change
  TD Cowen Maintains Xencor(XNCR.US) With Buy Rating
  Market Newswire · 2026/5/12
• Rating change
  Truist Financial Maintains Xencor(XNCR.US) With Buy Rating, Cuts Target Price to $27
  Market Newswire · 2026/7/7
• Wedbush Maintains Xencor(XNCR.US) With Buy Rating, Maintains Target Price $30
  Market Newswire · 2026/9/25
• Rating change
  BofA Securities Maintains Xencor(XNCR.US) With Hold Rating, Cuts Target Price to $17
  Market Newswire · 2026/5/8
• Barclays Maintains Xencor(XNCR.US) With Buy Rating, Raises Target Price to $35
  Market Newswire · 2026/9/11
• Rating change
  J.P. Morgan Maintains Xencor(XNCR.US) With Hold Rating, Raises Target Price to $14
  Market Newswire · 2026/5/11
• Rating change
  Barclays Maintains Xencor(XNCR.US) With Buy Rating, Maintains Target Price $27
  Market Newswire · 2026/7/30
• Rating change
  A Quick Look at Today's Ratings for Xencor(XNCR.US), With a Forecast Between $20 to $44
  Market Newswire · 2026/8/7
• Rating change
  Piper Sandler Maintains Xencor(XNCR.US) With Buy Rating, Raises Target Price to $33
  Market Newswire · 2026/5/8
• BofA Securities Maintains Xencor(XNCR.US) With Hold Rating, Raises Target Price to $26
  Market Newswire · 2026/9/21
• Rating change
  William Blair Maintains Xencor(XNCR.US) With Buy Rating
  Market Newswire · 2026/8/4
• Rating change
  Cantor Fitzgerald Maintains Xencor(XNCR.US) With Buy Rating, Maintains Target Price $44
  Market Newswire · 2026/8/10
• Truist Financial Maintains Xencor(XNCR.US) With Buy Rating, Announces Target Price $29
  Market Newswire · 2026/9/28
• Rating change
  Truist Financial Maintains Xencor(XNCR.US) With Buy Rating
  Market Newswire · 2026/7/30
• Raymond James Maintains Xencor(XNCR.US) With Buy Rating, Raises Target Price to $46
  Market Newswire · 2026/9/1
• Rating change
  Analysts' Opinions Are Mixed on These Healthcare Stocks: GoodRx Holdings (GDRX), Xencor (XNCR) and PepGen Inc. (PEPG)
  TipRanks · 2026/8/6
• Rating change
  Analysts Conflicted on These Healthcare Names: Ginkgo Bioworks Holdings (DNA), Xencor (XNCR) and Alto Neuroscience, Inc. (ANRO)
  TipRanks · 2026/5/11

Headlines are aggregated automatically and are not independently verified or edited by our team.